Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

Frédéric Bibeau; Evelyne LOPEZ-CRAPEZ; Jean-Christophe Sabourin; Florence BOISSIERE-MICHOT; Frédénc DI FIORE; Simon Thezenas; Marc Ychou; France Blanchard; Aude Lamy; Frédérique PENAULT-LLORCA; Thierry Frebourg; Pierre Michel

doi:10.1200/JCO.2008.18.0463

Retour

Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

Article de revue

Avec comité de lecture

Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan

Frédéric Bibeau, Evelyne LOPEZ-CRAPEZ, Jean-Christophe Sabourin, Florence BOISSIERE-MICHOT, Frédénc DI FIORE, Simon Thezenas, Marc Ychou, France Blanchard, Aude Lamy, Frédérique PENAULT-LLORCA, …

Journal of clinical oncology, Vol.27(7), pp.1122-1129

01/03/2009

DOI: https://doi.org/10.1200/JCO.2008.18.0463

PMID: 19164213

Résumé

Biological and medical sciences

Gastroenterology. Liver. Pancreas. Abdomen

Medical sciences

Stomach. Duodenum. Small intestine. Colon. Rectum. Anus

Tumors

Indicateurs

1 Consultations de la notice

See more details

Détails

Titre: Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
Créateurs - sans rôle: Frédéric Bibeau - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Evelyne LOPEZ-CRAPEZ - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Jean-Christophe Sabourin - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Florence BOISSIERE-MICHOT - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Frédénc DI FIORE - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Simon Thezenas - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Marc Ychou - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
France Blanchard - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Aude Lamy - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Frédérique PENAULT-LLORCA - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Thierry Frebourg - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Pierre Michel - Departments of Pathology, Biology, Biostatistics, and Oncology, Centre Regional de Lutte Contre le Cancer Val d'Aurelle-Paul Lamarque, Montpellier, France
Détails de publication: Journal of clinical oncology, Vol.27(7), pp.1122-1129
Éditeur: American Society of Clinical Oncology
Nombre de pages: 8
Identifiants: 99141150609311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article